300% increase, page-8

First 8 Last

Share
Profile

Follow
TobyCrew

623 Posts.

292

02/07/22

16:16

Post #: 62335948
Share

Originally posted by Biljor: ↑

The FDA will have their own guidelines for patient approval for the trial and for data collection. The independent study will help give the submission more credibility but I doubt it will count towards the study.

The advantage is current patient studies allow the market to see results before we get the FDA trial. That's the negotiation advantage. if we get take over offers once FDA trial is approved WP has a lot more bargaining power because there are results that aren't speculative he can hold in his play book.

Plus the experiences from these trials will be invaluable and any non critical changes (like doctors wanting different packaging to make opening in theatre easier and all those insignificant significant things) can be made before we get started.

There are huge advantages to what we're doing now, regardless of if we can or cannot add data to the FDA trial.

We've moved at incredible speed to get from valve concept to here and we should appreciate that. In the scheme of things for the industry, we are still moving fast.

exciting times

Expand

Thanks. great feedback. makes sense.

AVR Price at posting: $29.30 Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

Monday's HotCopper trends: Boss guidance, Botanix quarterly | July 28

Listen: HotCopper Wire Podcast 019 – Dreaming of the 9,000s

Red flags in the market to watch: How to spot trouble before it hits your portfolio

TMG

Veteran executive to help turn Trigg into leading US-based antimony producer

I88

Infini remobilising at Portland Creek after geo specialists line up 12 'priority' targets

First 8 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $5.05		Change 0.200(4.12%)		Mkt cap ! $78.29M

Open	High	Low	Value	Volume
$4.86	$5.05	$4.86	$10.89K	2.18K

Buyers (Bids)

No.	Vol.	Price($)
1	1212	$4.87

Sellers (Offers)

Price($)	Vol.	No.
$5.05	198	1

View Market Depth

No.	Vol.	Price($)
1	1212	4.870
1	454	4.860
2	2144	4.850
1	882	4.840
1	209	4.780

Price($)	Vol.	No.
5.050	198	1
5.140	5270	2
5.150	1212	1
5.200	2906	3
5.220	2066	1

Last trade - 13.02pm 28/07/2025 (20 minute delay)

AVR (ASX) Chart

300% increase, page-8

Monday's HotCopper trends: Boss guidance, Botanix quarterly | July 28

Listen: HotCopper Wire Podcast 019 – Dreaming of the 9,000s

Red flags in the market to watch: How to spot trouble before it hits your portfolio

Veteran executive to help turn Trigg into leading US-based antimony producer

Infini remobilising at Portland Creek after geo specialists line up 12 'priority' targets

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

300% increase, page-8

Top Stories

Monday's HotCopper trends: Boss guidance, Botanix quarterly | July 28

Listen: HotCopper Wire Podcast 019 – Dreaming of the 9,000s

Red flags in the market to watch: How to spot trouble before it hits your portfolio

Veteran executive to help turn Trigg into leading US-based antimony producer

Infini remobilising at Portland Creek after geo specialists line up 12 'priority' targets

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News